Searched for
ADJUSTED EBITDA
Aragen Life Sciences files draft papers with Sebi to raise funds through IPOAragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repa...- Systematix initiates coverage on Timex Group India with Buy rating. Check target priceSystematix has initiated coverage on Timex Group India with a Buy rating and a target price of Rs 820, implying around 30% upside. The brok...
- Delivery Hero lifts 2026 outlook on strong growth amid Uber takeover bidIts gross merchandise value, total value of all goods sold through the marketplace, is now expected to grow 9% to 11% this year, compared ...
- Motilal Oswal initiates coverage on Adani Enterprises with Buy, sees 25% upside. Here’s whyMotilal Oswal has initiated coverage on Adani Enterprises with a Buy rating and a target price of Rs 3,880, implying 25% upside from the pr...
- In 2025, First Solar began production at a 2.4-million-square-foot Louisiana plant. 1 year later, it can turn raw glass into 12 finished panels every minuteA massive Louisiana solar panel factory operates independently of new import tariffs. This plant produces panels using a unique cadmium tel...
- Buy, Sell or Hold? Morgan Stanley maintains buy on Vishal Mega Mart; Emkay Global initiates coverage on Urban CompanyBrokerages see strong upside potential in Vishal Mega Mart, Urban Company and Hexaware Technologies, citing leadership continuity, service ...
- Urban Company sues Kent RO over ads targeting its Native water purifiersUrban Company has sued Kent RO Systems in the Delhi High Court over advertisements calling its Native water purifiers’ two-year service and...
- ETMarkets Management Talk | CleanMax’s next growth phase: 1.5 GW capacity addition target, Rs 3,000 crore EBITDA by FY28, says Kuldeep JainCleanMax targets 1.5 GW capacity additions in FY27 and over Rs 3,000 crore EBITDA by FY28. Growth is driven by data centres, AI, Make in In...
- Jefferies retains Buy on Crompton Greaves; sees up to 29% upsideJefferies retained its Buy rating on Crompton Greaves Consumer Electricals with a Rs 330 target, implying nearly 29% upside. The brokerage ...
- Zaggle Prepaid shares jump 3% , extend 3-day rally to 16%. What's driving the rally?Zaggle Prepaid Ocean Services shares rose on Thursday, extending their three-day rally to 16% after Vijay Kedia-backed Kedia Securities acq...
- Vijay Kedia buys Rs 33 crore stake in Zaggle Prepaid Ocean Services via bulk deal, stock skyrockets 17%Zaggle Prepaid Ocean Services shares surged after Kedia Securities, owned by investor Vijay Kedia, acquired 20 lakh shares, or a 1.48% stak...
- Swiggy expands leadership across businesses as quick commerce competition heats upHimavant Kurnala has been appointed chief growth and product officer (CGPO) of Instamart, while Nitesh Garg has been appointed the chief te...
- Zaggle Prepaid Ocean Services crashes 20%, hits lower circuit after Q1 PAT declines 33% YoYZaggle Prepaid Ocean Services shares hit the lower circuit after the company reported a sharp year-on-year decline in Q1FY27 profit, despit...
- PhysicsWallah shares rally 8% after Q1 loss narrows, revenue rises 24% YoY. Should you buy?PhysicsWallah shares gained sharply after the edtech company reported improved Q1FY27 performance, with revenue rising and losses narrowing...
- ETMarkets Management Talk | SIS bets on healthcare, BFSI, manufacturing for next leg of security growth: Rituraj SinhaFor SIS, this transition is opening up a fresh growth opportunity across sectors such as healthcare, BFSI, manufacturing, logistics, e-comm...
- Lenskart’s Meller sunglasses are Ray-Ban of the future, says Jefferies. Here’s why Wall Street giant is bullishLenskart’s strong Q1 FY27 performance, marked by sharp profit growth, revenue expansion and improving margins, has strengthened the bullish...
- TVS Supply Chain Solutions Q1 profit rises on strong business wins, freight volumesTVS Supply Chain Solutions reported a 28.7% rise in Q1FY27 revenue and 34% growth in adjusted EBITDA, supported by strong volumes and globa...
- Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...
- Eternal vs Swiggy: The quick commerce war is on. Which stock should you own after Q1?The rivalry in the quick commerce sector heats up as Q1 results show stark contrasts between Eternal and Swiggy. While Swiggy leans towards...
- Swiggy targets Rs 10,000 crore in annual adjusted Ebitda in five yearsSwiggy aims for ten thousand crore rupees adjusted Ebitda by fiscal year thirty-one. Its food delivery business will contribute five thousa...
Load More
